GAMMA Investing’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$119K Buy
1,321
+193
+17% +$16.4K ﹤0.01% 1676
2026
Q1
$94.3K Sell
1,128
-816
-42% -$67K ﹤0.01% 1718
2025
Q4
$178K Buy
1,944
+168
+9% +$16.1K 0.01% 1124
2025
Q3
$168K Sell
1,776
-230
-11% -$21.6K 0.01% 1099
2025
Q2
$210K Buy
2,006
+435
+28% +$41.2K 0.01% 878
2025
Q1
$139K Buy
1,571
+323
+26% +$33.1K 0.01% 988
2024
Q4
$120K Buy
1,248
+309
+33% +$28.8K 0.01% 974
2024
Q3
$76.9K Buy
939
+344
+58% +$26.5K 0.01% 1183
2024
Q2
$51.3K Buy
595
+318
+115% +$25.7K 0.01% 1179
2024
Q1
$22.6K Buy
277
+151
+120% +$11.8K ﹤0.01% 1564
2023
Q4
$9.52K Buy
+126
New +$8.74K ﹤0.01% 1930

Other funds holding HQY

GAMMA Investing's HQY Position: Q2 2026 in Review

GAMMA Investing increased its HealthEquity (HQY) stake by 17% in Q2 2026, buying an estimated $16.4K and bringing the position to 1,321 shares worth $119K. The position accounts for ﹤0.01% of the portfolio, ranked #1676.

GAMMA Investing first reported a position in HQY in Q4 2023 and has held it in 11 quarters since. The position peaked at $210K in Q2 2025. 56 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • GAMMA Investing held 1,321 shares of HealthEquity worth $119K as of Q2 2026.
  • GAMMA Investing bought 193 HealthEquity shares in Q2 2026, an estimated $16.4K.
  • HealthEquity made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #1676 holding.
  • GAMMA Investing first reported a position in HealthEquity in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's HealthEquity position peaked at $210K in Q2 2025.
  • 56 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.